Search Results
| Year | ID | Type | Category | Title | Authors |
|---|
| 2019 | MDC16 | Poster | Multidisciplinary Care |
Description of an Interdisciplinary Fingolimod (Gilenya) First Dose Observation Clinic |
Steven P Merrill, PharmD and Lynn Do, PharmD, Pharmacy, University of California, San Francisco, San Francisco, CA |
| 2019 | MOC01 | Poster | Methods of Care |
Insights on the Management of MS Patients: Preventing Therapeutic Inertia and Understanding the Benefits of Early High-Efficacy Treatment Approaches |
Zachary Contreras, PharmD1, Jeffrey D Dunn, PharmD2, Tamara Howerton, RPh3, Kevin Duhrkopf, PharmD4, Louis Hudspeth, PhD4, Manny Nunez, PharmD4, Michael Raffaele, MD4 and Aaron Boster, MD5, (1)Independent Contractor, Sacramento, CA, (2)Magellan Rx, Salt Lake City, UT, (3)Magellan Rx, Germantown Hills, IL, (4)Sanofi, Cambridge, MA, (5)OhioHealth Multiple Sclerosis Center, Columbus, OH |
| 2019 | MOC02 | Poster | Methods of Care |
Pilot Study: The Assessment of Visual Function in Patients with Multiple Sclerosis Combining Visual Evoked Potentials and Red-I-Test Mobile App. |
Jake J Reznik, B. Kin1, Joseph Chung, B. Sc1, Shell (Xue) Han, B. Sc2 and George Medvedev, MD, FRCPC3, (1)University of British Columbia, Vancouver, BC, Canada, (2)Simon Fraser University, Burnaby, BC, Canada, (3)Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada |
| 2019 | MOC03 | Poster | Methods of Care |
Pilot Study: The Assessment of Visual Function in Patients with Multiple Sclerosis Combining Visual Evoked Potentials and “Red-I-Test” Mobile App |
Jake J Reznik, Bachelors of Kinesiology, Kinesiology, Mr., Vancouver, BC, Canada, Joseph Chang, Bacelors of Science, UBC, Vancouver, BC, Canada, Shell Han, B. Sc, Simon Fraser University, Burnaby, BC, Canada and George Medvedev, MD, FRCPC, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada |
| 2019 | MOC04 | Poster | Methods of Care |
Optimizing Multiple Sclerosis Relapse Management: A Structured Approach |
Amy Perrin Ross, APN, MSN, CNRN, MSCN, Loyola University Chicago, Maywood, IL, Rany A Aburashed, DO, Institute for Neurosciences and Multiple Sclerosis, Owosso, MI, Robert K Shin, MD, Georgetown University Medical Center, Washington, DC, Stephen Krieger, MD, Icahn School of Medicine at Mount Sinai, New York City, NY, Regina Berkovich, MD, USC Medical Center, Los Angeles, CA, Barry Hendin, MD, Phoenix Neurological Associates, Phoenix, AZ, Maria K Houtchens, MD, Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN, Augusto Miravalle, MD, Neurology, University of Florida, Gainesville, FL, Bianca Weinstock-Guttman, MD, University at Buffalo, Buffalo, NY, Christen Kutz, PA, PhD, Colorado Springs Neurological Associates, Colorado Springs, CO and Robert C Sergott, MD, Wills Eye Hospital, Philadelphia, PA |
| 2019 | MOC05 | Poster | Methods of Care |
Mercy Clinic Neurology/Mercy MS Care in Collaboration with Mercy Specialty and Infusion Implements Home Infusions of Ocrelizumab |
Whitney Feichtner, APRN, FNP-C, Mercy Clinic Neurology, Saint Louis, MO, Rachel Sauer, FNP-BC, Mercy Specialty and Home Infusion, Saint Louis, MO, Robert Street, MBA, RPh, Mercy Specialty and Infusion Pharmacy, Saint Louis, MO, Jessica Schulte, RN, MSCN, Mercy Research Neurology, Saint Louis, MO and Amy Rauchway, DO, Mercy Clinic Neurology/Mercy MS Care, Saint Louis, MO |
| 2019 | MOC06 | Poster | Methods of Care |
Accessing Healthcare Services for Managing Multiple Sclerosis: Perspectives from Ontarians with MS |
Julie Petrin, PhD Candidate1, Marcia Finlayson, PhD, OT Reg (Ont), OTR2, Mary Ann McColl, B.Sc. (OT), M.H.Sc., Ph.D., M.T.S.3 and Catherine Donnelly, B.Sc.(OT), MSc, PhD1, (1)Rehabilitation Sciences, Queen’s University, Kingston, ON, Canada, (2)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (3)Rehabilitation Sciences, Queen’s University, Kinsgton, ON, Canada |
| 2019 | MOC07 | Poster | Methods of Care |
EDSS 6.0 and 6.5: A Finer Method for Scoring |
Jill R Nelson, RN BScN MSCN, Tatstsyana Kadach, MEng, Anna Kazimirchik, RN MSCN and Galina Vorobeychik, MD, FRCPS(C), CMSC, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada |
| 2019 | MOC08 | Poster | Methods of Care |
Physical and Attitudinal Barriers to Health Promotion in Women with Multiple Sclerosis in Canada: A Web Based Study |
Christine Short, MD, FRCPC, FACP1, Emily Patterson, MD1 and Joanne Courtney-Walker, BSc, RN2, (1)Medicine, Dalhousie University, Halifax, NS, Canada, (2)Nova Scotia Health Authority, Halifax, NS, Canada |
| 2019 | NDM01 | Poster | Neuroimmunology and Disease Models |
Differential Signature of IM IFN-Beta-1a Vs. SQ Peg-IFN-Beta-1a: JAK/STAT Pathway and Proteins |
Anthony T Reder, MD1, Quentin Howlett-Prieto, BS2, Grace Park, BS2, Yaerin Song, BA2, Chineze Egwudo, BS3 and Xuan Feng, PhD2, (1)Neurology, University of Chicago, Chicago, IL, (2)Neurology, The University of Chicago, Chicago, IL, (3)Neurology, The University of Chicago, c, IL |
| 2019 | NDM02 | Poster | Neuroimmunology and Disease Models |
Long-Term Reduction in 48-Week Confirmed Disability Progression after 5 Years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis |
Stephen L Hauser, MD1, Ludwig Kappos, MD, PhD2, Xavier Montalban, MD, PhD3,4, Amit Bar-Or, MD5, Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath6, Fabian Model, PhD7, Stanislas Hubeaux, MSc7, Lahar Mehta, PhD8 and Jerry S Wolinsky, MD9, (1)University of California San Francisco, San Francisco, CA, (2)University Hospital Basel, University of Basel, Basel, Switzerland, (3)Division of Neurology, University of Toronto, Toronto, ON, Canada, (4)Vall d’Hebron University Hospital, Barcelona, Spain, (5)Department of Neurology and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (6)Queen Mary University of London, London, United Kingdom, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Genentech, Inc., South San Francisco, CA, (9)McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX |
| 2019 | NDM03 | Poster | Neuroimmunology and Disease Models |
Immune-Mediated Neurodegeneration in MS: The Inflammatory Proteins MRP8 & MRP14 Display TLR4-Dependent Cytotoxicity in a Neuronal-like Cell Line |
Nikki A McLean, PhD1,2 and Michael C Levin, MD1,2,3, (1)Cameco MS Neuroscience Research Centre, University of Saskatchewan, Saskatoon, SK, Canada, (2)Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Neurology, University of Saskatchewan, Saskatoon, SK, Canada |
| 2019 | NDM04 | Poster | Neuroimmunology and Disease Models |
Repository Corticotropin Injection (RCI: H.P. Acthar Gel) Enhances Remyelination after Cuprizone-Induced Demyelination |
Dale Wright, PhD and Rick Fitch, PhD, Pharmacology, Mallinckrodt Pharmaceuticals, Hazelwood, MO |
| 2019 | NDM05 | Poster | Neuroimmunology and Disease Models |
Inhibition of Bruton’s Tyrosine Kinase Prevents Inflammatory Macrophage Differentiation: A Potential Role in Multiple Sclerosis |
Yasemin Beguem Alankus, MD1, Roland Grenningloh, MD2, Philipp Haselmayer, MD1, Andrew Bender, MD2 and Julia Bruttger, MD1, (1)Merck KGaA, Darmstadt, Germany, (2)Research and Development Institute, EMD Serono, Inc., Billerica, MA |
| 2019 | NDM06 | Poster | Neuroimmunology and Disease Models |
Interferon Signature and Regulation in Progressive Multiple Sclerosis: Effects of Sc IFN-Beta-1a |
Xuan Feng, PhD1, Quentin Howlett-Prieto, BS1, Yaerin Song, BA1, Grace Park, BS1, Chineze Egwudo, BS1 and Anthony T Reder, MD2, (1)Neurology, The University of Chicago, Chicago, IL, (2)Neurology, University of Chicago, Chicago, IL |
| 2019 | NDM07 | Poster | Neuroimmunology and Disease Models |
Phenotype and Transcriptome Analysis of Central Neural Lineage Populations in Multiple Sclerosis |
Jon P Williams, D.O., Ph.D., Neurology, United States Air Force, Wright-Patterson AFB, OH and Marcel M Daadi, Ph.D., NeoNeuron, LLC, San Antonio, TX |
| 2019 | NIB01 | Poster | Non-imaging Biomarkers |
Alemtuzumab Treatment Reduces Serum Neurofilament to Levels Comparable With Healthy Controls More Effectively Than SC IFNb-1a: CARE-MS I |
Evis Havari, MSc1, Nadia Daizadeh, PhD2, Christian Barro, MD3, Zuzanna Michalak, PhD3, David Leppert, MD3, Jean Godin, MD2, Srinivas Shankara, PhD1, Luke Chung, MD, MPH2, Nora Roesch, MD2, Carina Kaiser, MS4, Tarek A Samad, PhD1, Alan Jacobs, MD2, Ludwig Kappos, MD3 and Jens Kuhle, MD3, (1)Sanofi, Framingham, MA, (2)Sanofi, Cambridge, MA, (3)Neurologic Clinic and Policlinic, University Hospital Basel, Basel, Switzerland, (4)Sanofi, Baar, Switzerland |
| 2019 | NIB02 | Poster | Non-imaging Biomarkers |
Novel Biomarkers As Predictors of Disease Severity and Progression in Multiple Sclerosis |
Naseem Zomorodi, MS21, Chirag Patel, MD, PhD Candidate2, Gary Thomas, MD, MBA3, Mark D Meadowcroft, PhD4, Ian S Zagon, PhD2 and Patricia J McLaughlin, DEd2, (1)Penn State University College of Medicine, Hershey, PA, (2)Neural and Behavioral Sciences, Penn State University College of Medicine, Hershey, PA, (3)Neurology, Penn State University College of Medicine, Hershey, PA, (4)Neurosurgery, Penn State University College of Medicine, Hershey, PA |
| 2019 | NNN01 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Somatosensory Evoked Potential Testing Suggests Greater CNS Nerve Conduction Slowing in RRMS and SPMS than in PPMS |
Sarah Simmons, MD, PhD1, Marcia Ciol, PhD2, Dawn Ehde, PhD3, Ian Nelson, .4, Arielle Kloss, MD2, James D Bowen, MD5 and George H Kraft, MD, MS3, (1)Rehabilitation Medicine, University of Washington, Seattle, WA, (2)University of Washington, Seattle, WA, (3)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (4)Seattle, WA, (5)MS Center, Swedish Medical Center, Seattle, WA |
| 2019 | NNN02 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Depression, Anxiety, Fatigue, and Pain Affect Performance on the Brief International Cognitive Assessment for MS in Patients with Minimal to Moderate Neurologic Disability |
Christiane E Whitehouse, BSc, Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada and John D Fisk, PhD, Nova Scotia Health Authority, Halifax, NS, Canada; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada; Department of Medicine, Dalhousie University, Halifax, NS, Canada |
| 2019 | NNN03 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Imaging Cognitive Fatigue in Multiple Sclerosis: Objective Quantification of Cerebral Blood Flow during a Task of Sustained Attention Using ASL Perfusion fMRI |
Jason A Berard, PhD1,2, Zhuo Fang, PhD3, Lisa A.S. Walker, PhD4,5,6, Alyssa Lindsay-Brown, B.A.(hon)4, Leila Osman, M.A.7, Ian Cameron, PhD8, Roxana Cruce, M.D.4, Greg Cron, PhD8, Mark S Freedman, MSc, MD, FAAN, FRCPC9 and Andra M Smith, Ph.D.3,10,11, (1)University of Ottawa, Ottawa, ON, Canada, (2)Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada, (3)Psychology, University of Ottawa, Ottawa, ON, Canada, (4)Neuroscience, Ottawa Hospital Research Institute, Ottawa, ON, Canada, (5)Psychology, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada, (6)Psychology, Carleton University, Ottawa, ON, Canada, (7)St. Paul University, Ottawa, ON, Canada, (8)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (9)THe University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, (10)The Ottawa Hospital Research Institute, Ottawa, ON, Canada, (11)University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada |
| 2019 | NNN04 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
The Association between Infra/Supratentorial White Matter and Processing Speed in a Pilot Sample of Pediatric-Onset MS Patients |
Elisea De Somma, M.A.1, Julia O’Mahony, BSc2, Ritobrato Datta, PhD3, Brenda Banwell, MD2,3 and Christine Till, PhD, C.Psych1,2, (1)Psychology, York University, Toronto, ON, Canada, (2)Neurosciences and Mental Health Program, The Hospital for Sick Children, Toronto, ON, Canada, (3)Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA |
| 2019 | NNN05 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Cognitive Reserve in Pediatric-Onset MS: Examining Parental Education As a Predictor of Executive Functioning |
Emily Barlow-Krelina, MA1, Tracy Fabri, BA1, E Ann Yeh, MD2, Julia O’Mahony, BSc3, Raquel E Gur, MD, PhD4, Ruben Gur, PhD4, Kosha Ruparel, MSE4, Brenda Banwell, MD3,5 and Christine Till, PhD, C.Psych3, (1)Psychology, York University, Toronto, ON, Canada, (2)Department of Paediatrics, Division of Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (3)Neurosciences and Mental Health Program, The Hospital for Sick Children, Toronto, ON, Canada, (4)Penn-CHOP Lifespan Brain Institute and Departments of Psychiatry, Neurology and Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, (5)Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA |
| 2019 | NNN06 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Organic Catatonia in Tumefactive Multiple Sclerosis: A Case Report and Review of Current Literature |
Alise K Carlson, MD, Neurology, Cleveland Clinic Foundation, Cleveland, OH and Elias A Khawam, MD, Psychiatry, Cleveland Clinic, Cleveland, OH |
| 2019 | NNN07 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
The Relationship between Quality of Life and Cognition in MS: A Systematic Review |
Rhiannon Campden, MSc, Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada, Thomas Edwards, MSc, School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada, Yodit Tesfagiorgis, BSc, Microbiology and Immunology, Western University, London, ON, Canada and Lindsay Berrigan, PhD, Psychology, St. Francis Xavier University, Antigonish, NS, Canada |
| 2019 | NNN08 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Relapsing-Remitting Multiple Sclerosis Patients with Slowed Cognitive Processing Speed Are Impaired on Verbal, Visuospatial, and Working Memory Measures |
Mark D Zuppichini, MA1, Kathryn West, PhD2, Dinesh Sivakolundu, MD3 and Bart Rypma, PhD3, (1)School of Behavioral and Brain Sciences, University of Texas At Dallas, Richardson, TX, (2)Center for BrainHealth, Dallas, TX, (3)School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX |
| 2019 | NNN09 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Anxiety, Depression and Fatigue in Youth with Mog-Associated Neuroinflammation: A Preliminary Report |
Beyza Ciftci-Kavaklioglu, MD1, Giulia Longoni, M.D.1, Stephanie A Grover, MSc, CCRP2, Carmen Yea, MSc2 and E Ann Yeh, MD1, (1)Department of Paediatrics, Division of Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (2)Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada |
| 2019 | NNN10 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Cognitive Fatigue Interventions in Neurological Disease: A Systematic Review |
Alyssa Lindsay-Brown, B.A.(hon)1, Jason A Berard, PhD2,3 and Lisa A.S. Walker, PhD1,4,5, (1)Neuroscience, Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada, (3)University of Ottawa, Ottawa, ON, Canada, (4)Psychology, Carleton University, Ottawa, ON, Canada, (5)Psychology, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada |
| 2019 | NNN11 | Poster | Neurophysiology, Neuropsychology and Neuropsychiatry |
Evidence That Dysfunctional RNA Binding Proteins Contribute to Neuronal Dysfunction in MS |
Hannah Salapa, B.S.1, Lian Finch, B.Sc.1,2, Catherine Hutchinson, B.Sc. M.Sc.1, Bogdan Popescu, PhD3 and Michael C Levin, MD1,4,5,6, (1)Office of the Saskatchewan MS Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, (2)Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (4)Neurology, University of Saskatchewan, Saskatoon, SK, Canada, (5)Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (6)Cameco MS Neuroscience Research Centre, University of Saskatchewan, Saskatoon, SK, Canada |
| 2019 | PGM01 | Poster | Programs |
Excellence in Education for the Healthcare Team: How the CMSC Supports Its Mission with Innovative CE |
Lisa S. DeSantis, JD, Continuing Education, CMSC, Hackensack, NJ, Tina Trott, NA, CMSC, Hackensack, NJ and June Halper, MSN, ANP, FAAN, CEO-CMSC, Hackensack, NJ |
| 2019 | PGM02 | Poster | Programs |
Effect of Education on Physician Knowledge on Brain Atrophy and Neurodegeneration in RRMS |
Lionel Thevathasan, MD FRCS, Medical Strategy, Medscape LLC, Paris, France |
| 2019 | PGM03 | Poster | Programs |
Serving to Empower: The Ease Program, a Community-University Partnership |
Kathleen Healey, NP, PhD1, Renee Stewart, DNP2, Aubrie Lindner, MA2, Daryl Kucera, BS3 and Rana K. Zabad, MD4, (1)Neurologial Sciences, University of Nebraska, Omaha, NE, (2)Neurological Sciences, Nebraska Medicine, Omaha, NE, (3)MSforward, Omaha, NE, (4)NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE |
| 2019 | PGM04 | Poster | Programs |
Promoting Healthy Lifestyle Practices through a Multiple Sclerosis Health and Wellness Patient and Caregiver Education Series |
Shaina Meyer, OTR/L, MSCS1, Jennifer Nash, PT, DPT, NCS, CEEAA, MSCS, CDP1, Laura Kruskall, PhD, RDN, CSSD, LD, FACSM, FAND2, Kimberly Castello, C-IAYT, YTRX, E-RYT 500 Yoga Therapist3, Kara Barton, MSW, LCSW4, Marie LeGrand, MPH5, Amy B Sullivan, PsyD, ABPP6 and Carrie M Hersh, DO, MS1, (1)Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, (2)Nutrition Sciences, University of Nevada Las Vegas, Las Vegas, NV, (3)Kimberly Castello Yoga, Las Vegas, NV, (4)Leslie P. Weiner Center for Neurological Care and Research, Keck Medicine of USC, Los Angeles, CA, (5)Multiple Sclerosis Association of America, Chicago, IL, (6)Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH |
| 2019 | PGM05 | Poster | Programs |
China’s First Comprehensive Multiple Sclerosis Program: Novel Model to Replicate |
Ka-Ho Wong, BS1,2, Jun Feng Lin, MBA2, Kai Yao Jiang, MBA2, Xi Yuan Huang, BPT2,3, Qiaoyi Ho, LCSW2,4 and Yue Huang, MD2,5, (1)Neurology, University of Utah, Salt Lake City, UT, (2)Essenelf HealthCare Managment Institute, GuangZhou, China, (3)Physical medicine and rehabilitation, The Fifth Affiliated Hospital Sun Yat-Sen University, GuangZhou, China, (4)Social Work, Guangdong General Hospital, GuangZhou, China, (5)Neurology, Guangdong General Hospital, GuangZhou, China |
| 2019 | PGM06 | Poster | Programs |
The Effectiveness of the National Multiple Sclerosis Society’s Medical Student Mentorship Program |
Lynette Coleman, Director MS Professional Workforce Development, Services – Healthcare Access, National Multiple Sclerosis Society, New York, NY |
| 2019 | PGM07 | Poster | Programs |
The MS Standardized Training and Education Program with University Partners (MS STEP UP): Development of an Innovative Training Program Embedded in Entry-Level Dpt Education |
Katelyn Jarvis, SPT, Samantha D’Silva, SPT, Alexandra Wileman, SPT, Stacy Coffyn, SPT, Stacia Troshynski Brown, DPT, OCS and Catherine Siengsukon, PT, PhD, Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS |
| 2019 | PGM08 | Poster | Programs |
Innovative Approach to Knowledge Translation: Patients Enthusiastic about Real-Time Research Participation during a Community-Based MS Research Day |
Colleen Cochran, B.S.1, Sarah J Donkers, PT, PhD2, Katherine Knox, MD3, Pawan Kumar, B.A.1, Aman Saini, MD, MPH4, Audrey R Zucker-Levin, PhD, PT, MBA5 and Michael C Levin, MD6,7, (1)Office of the Saskatchewan MS Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, (2)College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, (3)Physical Medicine and Rehabilitation, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada, (4)Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada, (5)Physical Therapy, University of Saskatchewan, Saskatoon, SK, Canada, (6)Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (7)Office of the Saskatchewan MS Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada |
| 2019 | PSF01 | Poster | Psychosocial Factors |
Prevalence of Hoarding and Cluttering Disorder in Multiple Sclerosis Patients |
Esti Chapman, BA1, Talia Schiff, BA1, Zoe Rimler, CCRC2, Allyson Reid, BA2, Tamar Bacon, BA2 and Joshua Bacon, PhD3,4, (1)Yeshiva University, New York, NY, (2)Multiple Sclerosis Comprehensive Care Center, NYU Langone Health, New York, NY, (3)Neurology, NYU School of Medicine, New York, NY, (4)Psychology, Yeshiva University, New York, NY |
| 2019 | PSF02 | Poster | Psychosocial Factors |
Correlates of Self-Reported Cognitive Deficits in Persons with MS |
Janet Morrison, PhD, RN, MSCN, Heather Becker, PhD, Research Scientist and Alexa Stuifbergen, PhD, RN, FAAN, Dean, School of Nursing, The University of Texas at Austin, Austin, TX |
| 2019 | PSF03 | Poster | Psychosocial Factors |
Reliability and Validity of the 25-Item Multiple Sclerosis Resiliency Scale |
Krina Patel, BS1,2, Abbey J Hughes, PhD2, Aeysha Brown, MA1,2, Meghan Beier, PhD2, Ellen M Mowry, MD, MCR3 and Kathryn C Fitzgerald, ScD3, (1)American School of Professional Psychology at Argosy University – Northern Virginia, Arlington, VA, (2)Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD |